Medications

Rival obesity drugs seek out patients, and acceptance

Between 1999 and 2012, the Food and Drug Administration gave its blessing to exactly zero new weight-loss drugs. Then, starting in June of last year, the agency approved two such medications, in a span of 20 days.

Medications

US panel wants changes to Avandia safety measures (Update)

US government health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as previously ...

Medications

FDA weighs lifting safety restrictions on Avandia (Update 2)

A former blockbuster diabetes pill that was subjected to major safety restrictions in 2010 may be less risky than once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug Avandia.

Medications

EU OKs Bristol-Myers, AstraZeneca diabetes drug

(AP)—Drugmakers Bristol-Myers Squibb Co. and AstraZeneca PLC say their experimental diabetes pill has gotten its first major approval, in the European Union.

Medications

FDA approves first diabetes-cholesterol combo pill

(AP) -- The first combination pill for the millions of people with the dangerous combination of diabetes and high cholesterol won U.S. approval Friday, offering convenience - and savings - to patients taking multiple pills.

Health

Teenage stroke -- a frightening trend

Stroke has generally been considered a disease of the elderly, but the incidence of stroke in children and teens has increased in recent years. The American Heart Association Heart Disease and Stroke Statistics 2011 Data ...

Medications

FDA questions safety of experimental diabetes drug

(AP) -- Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers Squibb and AstraZeneca.

page 2 from 3